American Diabetes Association

Three Vanderbilt faculty members are diving into a "chicken-and-egg" problem of type 2 diabetes: Does the disease change beta-cell subtypes? Or do changes in the cells cause diabetes? Guoqiang Gu, Emily Hodges and Ken Lau have come up with a new method of studying the subtypes that can track them through different stages instead of just once when they're fully developed. "Thanks to this and other research, it may be possible to one day create a diet supplement for pregnancy that could reduce the risk of diabetes for babies," Gu said. Read More

Vanderbilt researchers have identified a signaling pathway that promotes kidney fibrosis in patients with diabetes — and that could be targeted with an existing approved medication. Read More

Men are more susceptible to progressive kidney disease than women; new VUMC studies point to differences in the expression and activation of the EGF receptor. Read More

Potassium channels in a cellular organelle regulate calcium flux and appear to play a critical role in pancreatic beta cell health. Read More

Daryl Granner, M.D., professor of Molecular Physiology and Biophysics, emeritus, at Vanderbilt, has been recognized for outstanding achievements in diabetes research and training by the American Diabetes Association. Read More

A new method developed at Vanderbilt will speed the search for potential therapeutics for diabetes: compounds that stimulate the replication of insulin-producing beta cells. Read More

Parenting behaviors may be an important target for improving outcomes in adolescents with diabetes. Read More

When the Mullis family straps on their helmets on June 11 to ride in the local Tour de Cure, one of a series of cycling events held nationally to benefit the American Diabetes Association (ADA), they will remember a day seven years ago that motivated their annual participation in the event. Read More

Maureen Gannon, Ph.D., associate professor of Medicine, has been appointed chair of the American Diabetes Association (ADA) Scientific Session planning committee. Read More

Alvin Powers, M.D., director of the Vanderbilt Diabetes Center, has been named president-elect, Medicine and Science, of the American Diabetes Association (ADA) for 2016. Read More

The growth factor FGF1 induces the growth of new insulin-producing beta cells and may help treat type 2 diabetes. Read More

Using revolutionary CRISPR technology, Vanderbilt investigators have developed a fast and simple method to simultaneously turn off multiple genes in order to study complex diseases. Read More

Alvin Powers, M.D., professor of Medicine and Molecular Physiology and Biophysics, has been named to the American Diabetes Association Board of Directors. Read More

Gaining and losing weight during “yo-yo dieting” may contribute to an exaggerated immune response in fat tissue that increases metabolic dysfunction more than steady weight gain alone. Read More

The statistics are jarring. More than 25.8 million children and adults in the United States — 8.3 percent of the population — have diabetes. And predictions are that one in three people will have the chronic disease by 2050. Read More

Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol. Read More

The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home. Read More